Clinical pharmacokinetics of clozapine in chronic schizophrenic patients.
The clinical pharmacokinetics of clozapine, an atypical neuroleptic, was evaluated in 10 chronic schizophrenic male patients after intravenous and oral administration. The mean equilibrium-state concentration ratio between blood and plasma was experimentally determined to be 0.87. The average values for blood clearance, hepatic extraction ratio and oral bioavailability were 250 ml/min, 0.2 and 0.27, respectively. Plasma concentration peaked on average at 3 h. The mean volume of distribution at steady-state and the terminal half-life was 1.6 l/kg and 10.3 h, respectively. A large fraction of the dose is most probably metabolized by some extrahepatic presystemic routes. The large inter-individual variability in the bioavailability and clearance is probably the main reason for large variation in the steady-state plasma level in patients receiving the same oral dosage regimen.
Cheng
Y F
YF
Department of Biopharmaceutics and Pharmacokinetics, University of Uppsala, Sweden.
Lundberg
T
T
Bondesson
U
U
Lindström
L
L
Gabrielsson
J
J
D000284:Administration, Oral; D000328:Adult; D002908:Chronic Disease; D003024:Clozapine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003984:Dibenzazepines / Q000493:pharmacokinetics*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D003984:Dibenzazepines; D003024:Clozapine